May 12, 2018 - This cancer-focused biotech will take plenty of shots on goal in the years ahead.
May 01, 2018 - Incyte Corp. (NASDAQ:INCY)Q1 2018 Earnings CallMay 01, 2018 8:00 am ETExecutivesMichael Charles A. Booth - Incyte Corp.Hervé Hoppenot - Incyte Corp.Barry P. Flannelly - Incyte Corp.Steven H. Stein - I
May 01, 2018 - Incyte (INCY) reported disappointing results for the first quarter wherein the company reported a loss against expectation of earnings and sales too missed estimates.
May 01, 2018 - Incyte reported a loss in the first quarter while sales also beat estimates.
Apr 30, 2018 - Four pharma/biotech companies are set to release earnings report on May 1. Let's take a look into how the companies are placed ahead of the upcoming results.
Apr 30, 2018 - Incyte (INCY) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
Apr 27, 2018 - Incyte (INCY) is likely to beat on earnings when it reports first-quarter results on May 1 driven by strong Jakafi sales.
Apr 25, 2018 - The biotech sector grabbed headlines last week as a couple of biotechs reported results while few others came out with pipeline updates.
Apr 25, 2018 - Three biotechs reported devastating clinical trial failures this month. Here are the important takeaways.
Apr 25, 2018 - Lilly's first-quarter results looked good. Is it time to buy the big pharma stock?